The University of Oxford in partnership with AstraZeneca have begun vaccinations today for a new phase in human trials to test a COVID-19 vaccine ‘AZD2816’ in volunteers against the B.1.351 variant of concern – commonly known as the Beta variant. The Phase II/III trial, sponsored and led by AstraZeneca will recruit approximately 2,250 participants across […]